Botswana vs Democratic Republic of Congo: Average cost of drugs for extensively drug-resistant tuberculosis
Botswana
900 constant 2022 US$
in 2024
Democratic Republic of Congo
1,102 constant 2022 US$
in 2024
Botswana rank
44th
Democratic Republic of Congo rank
41st
Average cost of drugs for extensively drug-resistant tuberculosis over time
- Botswana
- Democratic Republic of Congo
How they compare
Democratic Republic of Congo currently reports 1,102 constant 2022 US$ against 900 constant 2022 US$ in Botswana, a difference of 202 constant 2022 US$.
That makes Democratic Republic of Congo's figure about 1.2 times Botswana's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Botswana ahead.
Botswana ranks 44th and Democratic Republic of Congo ranks 41st of 56 countries.
Across the 2 decades both report, Botswana averaged higher in 1 and Democratic Republic of Congo in 1.
Head to head by decade
| Decade | Botswana | Democratic Republic of Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 7,178 constant 2022 US$ | 6,113 constant 2022 US$ | 1,064 constant 2022 US$ | Botswana |
| 2020s | 1,200 constant 2022 US$ | 3,398 constant 2022 US$ | 2,198 constant 2022 US$ | Democratic Republic of Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of drugs for extensively drug-resistant tuberculosis, Botswana or Democratic Republic of Congo?
- Democratic Republic of Congo, at 1,102 constant 2022 US$ against 900 constant 2022 US$ in Botswana as of 2024.
- What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between Botswana and Democratic Republic of Congo?
- 202 constant 2022 US$, with Democratic Republic of Congo ahead.
- How many years of comparable data are there for Botswana and Democratic Republic of Congo?
- 5 years are reported by both, from 2017 to 2024.
- How do Botswana and Democratic Republic of Congo rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
- Botswana ranks 44th and Democratic Republic of Congo ranks 41st of 56 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.